2011 - Page 170 of 319 - Shapiro, Washburn & Sharp

Did Generic Drugmakers Get Relieved of Failure-to-Warn Liability?

In his latest post to our firm’s Norfolk Injuryboard blog, my colleague Rick Shapiro argues that federal lawmakers and the U.S. Food and Drug Administration must hold makers of generic medications and brand-name drugmakers to the same standards for warning patients about dangerous drug side effects. Rick’s concern over the unequal treatment of the pharmaceutical…

read more